Saturday, November 22, 2008

Rheumatoid Arthritis Home>
Rheumatoid Arthritis News>
Study looks at biologic med, cancer link

Study looks at biologic med, cancer link

(Medical News Today) UPDATED 2007-09-01

According to new research, biologic meds used to treat inflammatory conditions such as Crohn's disease and rheumatoid arthritis do raise patients' risk of skin cancers, including melanoma. But researchers say the data also shows that meds like Enbrel and Remicade do not increase users' risk of developing other cancers or cancer in general. Read full story >

See all Rheumatoid Arthritis News

Related: Enbrel, Remicade, Rituxan/MabThera

Bookmark

Was this helpful? Yes

Save to My Home
Want to keep this page handy for later? Click Save to My Home and we'll add it to your My Home area.

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyRACentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2008. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.